Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.41 - $18.6 $1,176 - $53,382
2,870 Added 12.88%
25,144 $12,000
Q3 2022

Nov 14, 2022

SELL
$0.57 - $34.65 $462,523 - $28.1 Million
-811,445 Reduced 97.33%
22,274 $19,000
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.41 $29,270 - $48,554
34,436 Added 4.31%
833,719 $780,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $936,800 - $2.02 Million
-807,587 Reduced 50.26%
799,283 $1.06 Million
Q4 2021

Feb 14, 2022

BUY
$2.46 - $8.74 $3.32 Million - $11.8 Million
1,348,203 Added 521.21%
1,606,870 $3.95 Million
Q3 2021

Nov 15, 2021

BUY
$5.1 - $9.39 $410,570 - $755,932
80,504 Added 45.19%
258,667 $2.21 Million
Q2 2021

Aug 16, 2021

BUY
$3.95 - $6.88 $224,573 - $391,155
56,854 Added 46.87%
178,163 $1.14 Million
Q1 2021

May 17, 2021

BUY
$2.01 - $5.55 $243,831 - $673,264
121,309 New
121,309 $539,000
Q4 2020

Feb 16, 2021

SELL
$1.73 - $2.13 $61,257 - $75,421
-35,409 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.76 - $2.17 $62,319 - $76,837
35,409 New
35,409 $63,000
Q4 2019

Feb 14, 2020

SELL
$0.84 - $1.2 $22,517 - $32,168
-26,807 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$0.95 - $1.11 $5,228 - $6,109
5,504 Added 25.84%
26,807 $25,000
Q2 2019

Aug 14, 2019

BUY
$1.03 - $1.32 $21,942 - $28,119
21,303 New
21,303 $24,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.